<i>Col2a1-ΔTβR1</i> transgenic mice exhibits elongated growth plate and increased proliferation of chondrocytes. by Bettina Keller (231677)

Cohort #2: hGRPs with FK-506/Rapamycin differentiated into astrocytes in SOD1^G93A cervical spinal cord. by Angelo C. Lepore (342760)

“…Arrowheads denote HuNA/GFAP double-labeled cells in panels <b>A</b> and <b>C</b>. Scale bars: 50 µm.</p>…”

Fig 5 - by Varun Tiwari (9258130)

Image_2_Stimulation of Let-7 Maturation by Metformin Improved the Response to Tyrosine Kinase Inhibitor Therapy in an m6A Dependent Manner.tif by Kai Li (205203)

Image_1_Stimulation of Let-7 Maturation by Metformin Improved the Response to Tyrosine Kinase Inhibitor Therapy in an m6A Dependent Manner.tif by Kai Li (205203)

Image_3_Stimulation of Let-7 Maturation by Metformin Improved the Response to Tyrosine Kinase Inhibitor Therapy in an m6A Dependent Manner.tif by Kai Li (205203)

Image_8_Stimulation of Let-7 Maturation by Metformin Improved the Response to Tyrosine Kinase Inhibitor Therapy in an m6A Dependent Manner.tif by Kai Li (205203)

Image_9_Stimulation of Let-7 Maturation by Metformin Improved the Response to Tyrosine Kinase Inhibitor Therapy in an m6A Dependent Manner.tif by Kai Li (205203)

Image_4_Stimulation of Let-7 Maturation by Metformin Improved the Response to Tyrosine Kinase Inhibitor Therapy in an m6A Dependent Manner.tif by Kai Li (205203)

Image_7_Stimulation of Let-7 Maturation by Metformin Improved the Response to Tyrosine Kinase Inhibitor Therapy in an m6A Dependent Manner.tif by Kai Li (205203)

Image_5_Stimulation of Let-7 Maturation by Metformin Improved the Response to Tyrosine Kinase Inhibitor Therapy in an m6A Dependent Manner.tif by Kai Li (205203)

Image_6_Stimulation of Let-7 Maturation by Metformin Improved the Response to Tyrosine Kinase Inhibitor Therapy in an m6A Dependent Manner.tif by Kai Li (205203)

Image_10_Stimulation of Let-7 Maturation by Metformin Improved the Response to Tyrosine Kinase Inhibitor Therapy in an m6A Dependent Manner.tif by Kai Li (205203)

Supplementary Material for: Impact of Liraglutide 3.0 mg on Metabolic Dysfunction-Associated Steatotic Liver Disease in Individuals with Obesity: A Real-World Study by figshare admin karger (2628495)

“…Introduction: Metabolic dysfunction-associated steatotic liver disease (MASLD), a prevalent condition, can progress to liver cirrhosis and hepatocellular carcinoma. …”

Vinculin concentration can influence maturation fraction. by Kailas Shankar Honasoge (17108745)

Differences in abundance of non-lipid molecules in liver of <i>Fmo5</i>^<i>-/-</i> and WT mice. by Ian R. Phillips (5074121)

“…Non-lipid data points were abstracted after analysis of all metabolites in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0286692#pone.0286692.s001" target="_blank">S1 Table</a> combined. …”

Efficacy of topical brinzolamide in children with retinal dystrophies by Brittni A. Scruggs (511698)

“…Four of the six treated patients exhibited a mild decrease in central macular thickness in both eyes during the study with all six treated patients having significantly improved vision at the first endpoint, 33.2 ± 8.2 months after treatment initiation. …”

H3N2 hexamaps for HAI titers. by Andrew F. Brouwer (12119842)

The application of rumen simulation technique (RUSITEC) for studying dynamics of the bacterial community and metabolome in rumen fluid and the effects of a challenge with <i>Clostr... by Stefanie U. Wetzels (3203955)

“…Along the time-line, there was no statistically significant change of the overall bacterial community, however, some phylotypes were enriched at certain time points. A decrease in <i>Fibrobacter</i> and <i>Elusimicrobia</i> over time was followed by an increase in <i>Firmicutes</i> and <i>Actinobacteria</i>. …”

H1N1 hexamaps for HAI titers. by Andrew F. Brouwer (12119842)